Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.Yoshiyuki Yamaguchi, Tetsuya Toge, Riki Okita et al.|PubMed|2005Cited by 19
HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.Yoshiyuki Yamaguchi, Tetsuya Toge, Katsuji Hironaka et al.|PubMed|2005Cited by 15